Clinical Trial Associate
Cellectis
Clinical Trial Associate
Cellectis
Develops allogeneic CAR-T cell therapies
The Clinical Trial Associate (CTA) supports clinical study teams in the execution and oversight of clinical trials under the direction of the Vice President, Development Operations, with day-to-day guidance from the assigned Study Lead. The CTA plays a key role in study start-up, ongoing trial execution, and close-out activities, with a primary focus on document management, trial tracking, and operational support.
This role contributes to the maintenance of inspection-ready trial documentation and systems, including the Trial Master File (TMF/eTMF) and Clinical Trial Management System (CTMS), in compliance with applicable regulatory requirements (GCP/ICH), internal SOPs, and company standards.
All activities are conducted in accordance with company policies, SOPs, and corporate values.
POSITION RESPONSIBILITIES
Clinical Trial Support
Trial Documentation & Systems
Study Tracking & Reporting
Meetings & Cross-Functional Collaboration
Compliance & Inspections
EDUCATION AND EXPERIENCE
TECHNICAL SKILLS & CORE COMPETENCIES
Proposed Compensation Range: 80,000 - 90,000
Cellectis develops immunotherapy treatments for cancer using gene-edited allogeneic CAR T cells. Its products rely on donor-derived T cells that are edited to remove T cell receptor activity and engineered to express a chimeric antigen receptor (CAR) that targets cancer cells. The goal is to create off-the-shelf CAR T therapies that are available quickly and at a lower cost than patient-specific (autologous) CAR T treatments. Cellectis works through research and development, clinical trials, and partnerships with other pharma companies, such as Sanofi, and generates revenue from licensing, milestone payments, and potential future product sales. The company differentiates itself by offering off-the-shelf solutions rather than custom-made therapies, aiming to broaden access to advanced cancer treatment.
Explore more opportunities at Cellectis